Prognostic values of tissue-resident CD8+T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma

Table 3 The correlation between CD103⁺ cells, CD8⁺T cells, and CD103⁺CD8⁺T cells in tumor tissues and clinical features of patients with ICC

Clinical parameters	Cases	Numbers of infiltrating CD103⁺ cells		χ²	P	Numbers of infiltrating CD8⁺T cells		χ²	P	Numbers of infiltrating CD103⁺CD8⁺T cells		χ²	P	Ratio of CD103⁺CD8⁺T/CD8⁺T cells		χ²	P
		Low	High			Low	High			Low	High			Low	High
Gender
Male	92	42	50	1.07	0.30	39	53	1.02	0.31	28	64	0.35	0.56	28	64	2.77	1.00
Female	57	31	26			29	28			20	37			25	32
Age (years)
< 62	71	34	37	0.03	0.86	30	41	0.61	0.43	20	51	0.81	0.37	22	49	1.03	0.31
≥ 62	77	38	39			37	40			27	50			30	47
Tumor size (cm)
< 5	38	12	26	3.57	0.06	13	25	2.27	0.13	2	36	11.99^a	< 0.001	11	27	0.67	0.41
≥ 5	99	49	50			48	51			34	65			36	63
T stage
T₁ + T₂	29	16	13	1.28^a	0.26	15	14	0.22^a	0.64	12	17	0.007^a	0.93	12	17	0.007^a	0.93
T₃ + T₄	4	1	3			1	3			1	3			1	3
N stage
N₀	43	18	25	0.01	0.94	18	25	0.01	0.94	13	30	0.25	0.62	19	24	0.37	0.55
N₁ + N₂	22	9	13			9	13			8	14			8	14
M stage
M₀	143	69	74	0.22^a	0.64	62	79	1.20^a	0.27	45	98	0.256^a	0.61	45	98	0.00^a	1.00
M₁	6	4	2			4	2			3	3			2	4
Pathological stage
I + II	83	40	43	0.02	0.90	36	47	0.27	0.60	26	57	0.02	0.90	10	73	10.22	0.001
III + IV	65	32	33			31	34			21	44			22	43

ISSN: 1477-7819